On Wednesday, Electronic Arts Inc. (NASDAQ:EA)’s shares declined -0.14% to $73.72.
Electronic Arts Inc. (EA) launched EA SPORTS™ Rory McIlroy PGA TOUR® for Xbox One®, the all-in-one games and entertainment system from Microsoft and PlayStation®4 computer entertainment system. The power of Frostbite™ 3, in addition to customizable gameplay styles and numerous ways to play all combine to truly deliver Golf Without Limits.
Electronic Arts Inc. develops, markets, publishes, and distributes game software content and online services for video game consoles, Internet-connected consoles, personal computers, mobile phones, and tablets worldwide. The company operates through EA Studios, EA Mobile, and Maxis divisions. It develops and publishes digital interactive entertainment games primarily under the The Sims, Madden NFL, EA SPORTS FIFA, Battlefield, FIFA Soccer, Need for Speed, Dragon Age, and Plants vs. Zombies brand names.
SUPERVALU INC. (NYSE:SVU)’s shares gained 2.01% to $9.14.
Supervalu Inc.(SVU) paid Sam Duncan, its president and CEO, 40 percent more in fiscal 2015 than it did in the previous year, boosting his total compensation to $6.92 million, up from $4.95 million in 2014.
Duncan, 63, has been CEO and president of the grocery wholesaler and retailer since February 2013, when he took over for Wayne Sales, who had been CEO for just seven months. Sales remains a member of Supervalu’s board of directors. The CEO turnover at Supervalu drew a lot of attention to the company’s high compensation for executives and directors.
Duncan’s jump in pay this year was mainly a result of a large stock award he received for the company’s continued positive turnaround, which comprises improved same-store-sales, adjusted earnings and shareholder returns, among others metrics, according to the company’s proxy. Supervalu’s total market capitalization grew from $1.59 billion at the end of fiscal 2014 to $2.59 billion at the end of fiscal 2015.
Former Target Corp. executive Gerald Storch has been nominated by the Supervalu board to continue as non-executive chairman, a position he’s held since January 2014. Since this January, Storch also has been CEO of Hudson’s Bay Co., a retail business group based in Brampton, Ontario.
SUPERVALU INC., together with its auxiliaries, operates as a grocery wholesaler and retailer in the United States. The company operates through three segments: Independent Business, Save-A-Lot, and Retail Food. The Independent Business segment offers wholesale distribution of various food and non-food products to independent retail customers, such as single and multiple grocery store independent operators, regional chains, and the military. As of February 28, 2015, this segment operated about 1,825 stores with a network spanning 41 states.
At the end of Wednesday’s trade, Synergy Pharmaceuticals Inc (NASDAQ:SGYP)‘s shares surged 2.04% to $7.99.
Synergy Pharmaceuticals Inc. (SGYP), a biopharmaceutical company focused on the development of novel treatments for gastrointestinal (GI) diseases and disorders, stated its financial results and business update for the three and six months ended June 30, 2015.
Plecanatide
- On June 17, 2015, we declared positive top-line results from the first of two pivotal phase 3 clinical trials evaluating the efficacy and safety of two different plecanatide treatment doses (3.0 mg and 6.0 mg), taken as a tablet once-a-day, in 1,346 adult patients with CIC. Both doses of plecanatide met the study’s primary endpoint and demonstrated statistical significance in the proportion of patients who were durable overall responders contrast to placebo during the 12-week treatment period (21.0% in 3.0 mg and 19.5% in 6.0 mg dose groups contrast to 10.2% in placebo; p<0.001 for both doses). The durable overall responder endpoint is the current FDA endpoint required for U.S. approval in CIC. Stool compriseency was the key secondary endpoint stated with top-line analyses; both plecanatide doses showed statistically noteworthyimprovement from baseline in Bristol Stool Form Scale (BSFS) scores contrast to placebo (mean enhance of 1.53 in 3.0 mg and 1.52 in 6.0 mg dose groups contrast to a mean enhance of 0.77 in placebo; p<0.001 for both doses). The observed improvements began at Week 1, continued throughout the 12-week treatment period, and returned towards baseline with no indication of an exaggerated or rebound effect following discontinuation of treatment. The most common adverse event was diarrhea but overall rates were low and did not enhance with dose (5.9% in 3.0 mg and 5.5% in 6.0 mg dose groups contrast to 1.3% in placebo). Only 15 patients in the trial (1.1%) practiced serious adverse events but there was no imbalance across treatment groups in either incidences or individual serious adverse events. Overall, the rates of withdrawal from treatment because of an adverse event were low (5.1 % in 3.0 mg and 5.0% in 6.0 mg dose groups contrast to 1.3% in placebo) and discontinuations due to diarrhea were infrequent (2.7% in 3.0 mg and 2.4% in 6.0 mg dose groups contrast to 0.4% in placebo). No clinically relevant abnormalities were observed in serum chemistries, hematology, urinalysis, ECG or vital signs measurements.
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders.
KB Home (NYSE:KBH), ended its Wednesday’s trading session with -0.62% loss, and closed at $15.27.
KB Home (KBH), one of the nation’s largest and most recognized homebuilders, declared the grand opening of Falcon Landing, a new neighborhood of attractively-priced homes on the growing Culebra Road corridor, featuring great community amenities and abundant nearby outdoor recreation destinations.
Located near Loop 1604 and Highway 151, Falcon Landing’s proximity to Medina Lake and Government Canyon State Natural Area provides terrific access to a variety of outdoor activities, counting boating and hiking. The community itself has several planned amenities, such as a swimming pool, a children’s playscape and a picnic pavilion. There will also be a private park that is predictable to open in 2016.
KB Home operates as a homebuilding company in the United States. It constructs and sells various homes, counting attached and detached single-family residential homes, townhomes, and condominiums primarily for first-time, move-up, and active adult homebuyers under the name KB Home.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
